I agree that this site is using cookies. You can find further informations here.
X
Haberland, Annekathrin
62  results:
Search for persons X
?
1

Lack of efficacy of mono‐mode of action therapeutics in COV..:

Haberland, Annekathrin ; Müller, Johannes
Chemical Biology & Drug Design.  99 (2021)  1 - p. 32-45 , 2021
Link: https://doi.org/10.1111/..
 
?
2

Aptamer BC 007's Affinity to Specific and Less-Specific Ant..:

Haberland, Annekathrin ; Krylova, Oxana ; Nikolenko, Heike...
Viruses.  13 (2021)  5 - p. 932 , 2021
Link: https://doi.org/10.3390/..
 
?
3

Case Report: Neutralization of Autoantibodies Targeting G-P..:

Hohberger, Bettina ; Harrer, Thomas ; Mardin, Christian...
Frontiers in Medicine.  8 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
4

Aptamer BC 007 - Efficient binder of spreading-crucial SARS..:

Weisshoff, Hardy ; Krylova, Oxana ; Nikolenko, Heike...
Heliyon.  6 (2020)  11 - p. e05421 , 2020
Link: https://doi.org/10.1016/..
 
?
5

A Three-Part, Randomised Study to Investigate the Safety, T..:

Becker, Niels-Peter ; Haberland, Annekathrin ; Wenzel, Katrin...
Clinical Drug Investigation.  40 (2020)  5 - p. 433-447 , 2020
Link: https://doi.org/10.1007/..
 
?
6

In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Huma..:

Davideit, Hanna ; Becker, Susanne ; Müller, Johannes...
European Journal of Drug Metabolism and Pharmacokinetics.  44 (2019)  4 - p. 567-578 , 2019
Link: https://doi.org/10.1007/..
 
?
7

Activation of T Lymphocytes as a Novel Mechanism in Beta1-A..:

Haberland, Annekathrin ; Müller, Johannes ; Wenzel, Katrin
Cardiovascular Drugs and Therapy.  33 (2019)  6 - p. 767-768 , 2019
Link: https://doi.org/10.1007/..
 
?
8

Antigen-free control wells in an ELISA set-up for the deter..:

Haberland, Annekathrin ; Müller, Johannes ; Wallukat, Gerd.
Analytical and Bioanalytical Chemistry.  410 (2018)  21 - p. 5101-5105 , 2018
Link: https://doi.org/10.1007/..
 
?
9

Characterization of Aptamer BC 007 Substance and Product Us..:

Weisshoff, Hardy ; Wenzel, Katrin ; Schulze-Rothe, Sarah...
Journal of Pharmaceutical Sciences.  107 (2018)  8 - p. 2033-2041 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Difference between beta1-adrenoceptor autoantibodies of hum..:

Wenzel, Katrin ; Schulze-Rothe, Sarah ; Müller, Johannes...
PLOS ONE.  13 (2018)  2 - p. e0192615 , 2018
Link: https://doi.org/10.1371/..
 
?
11

Performance and in-house validation of a bioassay for the d..:

Wenzel, Katrin ; Schulze-Rothe, Sarah ; Haberland, Annekathrin...
Heliyon.  3 (2017)  7 - p. e00362 , 2017
Link: https://doi.org/10.1016/..
 
?
12

High throughput bioassay for beta1-adrenoceptor autoantibod..:

Joshi-Barr, Shivanjali ; Haberland, Annekathrin ; Bartel, Sabine...
International Journal of Cardiology.  219 (2016)  - p. 98-104 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Aptamer BC007 for neutralization of pathogenic autoantibodi..:

Wallukat, Gerd ; Müller, Johannes ; Haberland, Annekathrin...
Atherosclerosis.  244 (2016)  - p. 44-47 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Aptamer BC 007 – A broad spectrum neutralizer of pathogenic..:

Haberland, Annekathrin ; Holtzhauer, Martin ; Schlichtiger, Alice...
European Journal of Pharmacology.  789 (2016)  - p. 37-45 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Neutralization of pathogenic beta1-receptor autoantibodies ..:

Haberland, Annekathrin ; Wallukat, Gerd ; Berg, Sabine...
Molecular and Cellular Biochemistry.  393 (2014)  1-2 - p. 177-180 , 2014
Link: https://doi.org/10.1007/..
 
1-15